drugset / Trial / NCT02147561

A Safety and Efficacy Study of BOTOX® in Korean Adults With Chronic Migraine

NCT02147561 ↗

Phase 4 Completed 280 enrolled Allergan
NaSingle-groupOpen-labelTreatment

Summary

This study will evaluate the safety and efficacy of BOTOX® treatment in Korean adults with chronic migraine.

Timeline

Start
2014-07
Primary completion
2015-02
Completion
2015-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Botulinum toxin type A Protein / enzyme biologic — Intramuscular

Indications